Weekly Market Update: Stocks Gain Nearly 1% as Industrials Rise and Energy Falls
Bloom and Moderna surged, while Fox and Accenture performed the worst.

Stock Market Update for the Trading Week Ended June 18
- The Morningstar US Market Index rose 0.94%.
- The best-performing sectors were industrials, up 3.01%, and technology, up 2.92%.
- The worst-performing sectors were energy, down 6.53%, and real estate, down 3.31%.
- Large-cap stocks gained 1.19%, mid-cap stocks rose 0.35%, and small-cap stocks fell 0.09%.
- Growth stocks gained 2.46%, blend stocks gained 0.88%, and value stocks fell 1.75%.
- The S&P 500 gained 0.93%, and the Nasdaq rose 2.43%.
- Of the 875 US-listed companies covered by Morningstar, 327, or 37%, were up, two were unchanged, and 545, or 62%, were down.
Bonds and Commodities
- Yields on 10-year US Treasury notes fell to 4.46% from 4.48%.
- Yields on 2-year US Treasury notes rose to 4.19% from 4.09%.
- West Texas Intermediate crude prices fell 9.02% to $76.69 per barrel.
- Comex Gold prices rose 0.38% to $4,223.70.
Top Stock Gainers
Western Digital WDC, Hims & Hers Health HIMS, Intellia Therapeutics NTLA, Moderna MRNA, and Bloom Energy BE were the top performers among US-listed stocks covered by Morningstar analysts.
- Western Digital topped the list, rising 32.61%, and it’s up 126.98% over the past three months. This no-moat company with a 1-star rating has increased 1116.72% over the past 12 months. The stock closed the week at $746.37, trading at a 72% premium to its fair value estimate of $415.00 per share.
- Hims & Hers was the second-best performer, with a weekly return of 32.25%. The 2-star stock has gained 27.66% over the last three months. Shares in this no-moat company are down 46.17% over the past 12 months. Hims & Hers wrapped up the week at $35.47, trading at a 39% premium to its fair value estimate of $23.00 per share.
- Intellia ranked third, with its stock rising 29.23%. The 4-star, no-moat stock has gained 12.76% over the last three months and 58.66% over the past 12. Intellia closed at $15.65, trading at a 44% discount to its fair value estimate of $27.00 per share.
- The fourth-best-performing stock was no-moat Moderna, which gained 28.09%. The 3-star stock has gained 14.59% over the last three months and is up 141.88% over the past 12. Moderna finished the week at $63.95, trading near its fair value estimate of $63.00 per share.
- Bloom stock climbed 26.4%. This no-moat company has seen an increase of 78.06% over the last three months and a rise of 1,235.47% over the past 12 months. The 1-star stock ended the week at $328.91 per share, trading at a 307% premium to its fair value estimate of $70.
Top Stock Losers
Accenture ACN, Fox FOXA, EPAM Systems EPAM, and Globant GLOB did the worst among US-listed stocks covered by Morningstar analysts.
- Accenture was the worst-performing stock of the week, falling 24.84%. This 5-star, narrow-moat company has fallen 20.65% over the past three months and 47.96% over the past 12. It ended the week at $127.98, trading at a 39% discount to its fair value estimate of $255.00 per share.
- Fox took the second spot, with a 20.79% price decline this week. The no-moat company, rated 4 stars, has fallen 11.97% over the past three months and 4.07% over the past 12. Closing at $52.15, the stock trades at a 21% discount to its fair value estimate of $65.00 per share.
- Next up is EPAM, which saw its stock price fall by 19.65% this week. The no-moat company with a 4-star rating has fallen 35.73% over the past three months and 47.98% over the past 12. At $76.85, the stock trades at a 36% discount to its fair value estimate of $136.00 per share.
- Globant rounds out the list with a 18% decline this week. This 4-star, no-moat company has fallen 22.45% over the past three months and is down 62.63% over the past 12. The stock closed the week at $30.74, trading at a 43% discount to its fair value estimate of $61.00 per share.
Highlights of This Week’s Market and Investing Events
- Wednesday, June 24: May New Home Sales
- Thursday, June 25: May Personal Income and Outlays report, Initial Unemployment Insurance Claims, May Durable Orders
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
